Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 2, 1999, Pages 97-103

  Hayes, D P ^a   Brink, A A T P ^a   Vervoort, M B H J ^a   Middeldorp, J M ^b   Meijer, C J L M ^a   Van Den Brule, A J C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Organon Teknika   (Netherlands)

Author keywords

Bcl 2; Cyclin B1; Epstein Barr virus associated diseases; Intercellular cell adhesion molecule 1; Interleukin 10

Indexed keywords

CYCLIN B1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; PROTEIN BCL 2;

ARTICLE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKOPLAKIA; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

EID: 0032894873     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.2.97     Document Type: Article

References (37)

1. Miller G. Epstein-Barr virus: biology, pathogenesis and medical aspects. In: Fields BN, Knipe DM, eds. Virology, 2nd ed., Version 2. New York: Raven Press, 1990:1921-58.
2. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95.8 Epstein-Barr virus genome. Nature 1984;310:207-11.
3. Vieira P, De Waal-Malefyt R, Dang MN, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991;88:1172-6.
4. Moore KW, Rousset F, Banchereau J. Evolving principles in immunopathology: interleukin-10 and its relationship to Epstein-Barr virus protein BCRFI. Springer Semin Immunopathol 1991;13:157-66.
5. Rousset F, Garcia E, Defrance T, et al. Interleukin-10 is a potent growth and differentiation factor for activated B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890-3.
6. Miyazaki I, Cheung RK, Dosch HM. Viral interleukin-10 is critical for the induction of B-cell growth transformation by Epstein-Barr virus. J Exp Med 1993;178:439-47.
7. Henderson S, Huen D, Rowe M, et al. Epstein-Barr virus-coded BHRFI protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 1993;90:8479-83.
8. Strockbine LD, Cohen JI, Farrah T, et al. The Epstein-Barr virus BARFI gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 1998;72:4015-21.
9. Wei MX, Moulin JC, Decaussin G, et al. Expression and tumorigenicity of the Epstein-Barr virus BARFI gene in human Louckes B-lymphocyte cell line. Cancer Res 1994;54:1843-8.
10. Qu L, Rowe DT. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992;66:3715-24.
11. Brooks L, Yao QY, Rickinson AB, et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNAI, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-97.
12. Brink AATP, Oudejans JJ Jiwa M, et al. Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies. Mol Cell Probes 1997;11:39-47.
13. Kievits T, van Gemen B, van Strijp D, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991;35:273-86.
14. Brink AATP Vervoort MBHJ, Middeldorp JM, et al. Nucleic acid sequence based amplification (NASBA) a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts and its comparison with RT-PCR. J Clin Microbiol 1998;36:3164-9.
15. Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993;177:339-49.
16. Van Gorp J, Brink A, Oudejans JJ, et al. Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol 1996;49:72-6.
17. Fåhracus R, Li RH, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988;42:329-38.
18. Cochet C, Martel-Renoir D, Grunewald V, et al. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 1993;197:358-65.
19. Wei MX, Ooka T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 1989;8:2897-903.
20. Jiwa NM, Kanavaros P, de Bruin PC, et al. Presence of Epstein-Barr virus harbouring small and intermediate sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells? J Pathol 1993;170:129-36.
21. Oudejans JJ, van den Brule AJC,Jiwa NM, et al. BHRF1, the Epstein-Barr virus (EBV) homologue of the bel-2 (proto-) oncogene, is transcribed in EBV associated B-cell lymphomas and in reactive lymphocytes. Blood 1995;86:1893-902.
22. Lau R, Packman G, Farrell PJ. Differential splicing of Epstein-Barr virus immediate-early RNA. J Virol 1992;66:6233-6.
23. Brooks LA, Lear AL, Young LA, et al. Transcripts from the Epstein-Barr virus BamHI a fragment are detectable in all three forms of virus latency. J Virol 1993;67:3182-90.
24. Compton J. Nucleic acid sequence-based amplification. Nature 1991;350:91-2.
25. Henke W, Herdel K, Jung K, et al. Betaine improves the PCR amplification of GC-rich sequences. Nucleic Acids Res 1997;25:3957-8.
26. Morré SA, Sillekens P, Jacobs MV, et al. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol 1996;34:3108-14.
27. Bijl J, van Oostveen JW, Kreike M, et al. Expression of HOXC4, -C5 and -C6 in human lymphoid cell lines, leukemias, and in benign and malignant lymphoid tissue. Blood 1995;87:1737-45.
28. Austin PJ, Flemington R, Yandava CN, et al. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRFI) in latently and lytically infected B lymphocytes. Proc Nad Acad Sci USA 1988;85:3678-82.
29. Murray PG, Swinnen LJ, Constandinou CM, et al. Bcl-2 but not its Epstein-Barr virus homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood 1996;87:706-11.
30. Sbih-Lammali F, Djennaoui D, Belaoui D, et al. Transcriptional expression of Epstein-Barr virus genes and protooncogenes in north African nasopharyngeal carcinoma. J Med Virol 1996;49:7-14.
31. Dawson CW, Eliopoulos AG, Dawson J, et al. BHRF1, a viral homologue of the bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 1995;9:69-77.
32. Brehmer-Andersson E, Lucht E, Lindskog S, et al. Oral hairy leukoplakia: pathogenetic aspects and significance of the lesion. Acta Derm Venereol 1994;74:81-9.
33. Cawson RA, Binnie W, Eveson J, eds. Color atlas of oral disease: clinical and pathologic correlations, 2nd ed. London: Wolfe, 1994.
34. Rooney CM, Rowe DT, Ragot T, et al. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 1989;63:3109-16.
35. Greenspan JS, Greenspan D, Lennette ET, et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 1985;313:1564-71.
36. Hudson GS, Bankier AT, Satchwell SC, et al. The short unique region of the B95.8 Epstein-Barr virus genome. Virology 1985;147:81-9
37. Wei MX, Deturenne-Tessier M, Decaussin G, et al. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 1997;14:3073-81.